Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Recent Releases In Global Health

Lancet Comment Calls For More Research Into Alcohol Use, HIV According to a Lancet Comment, “alcohol remains conspicuously absent from the larger field of research and programming in HIV and substance use. … Patterns of hazardous alcohol consumption prevail in countries with the most severe HIV epidemics, notably eastern and…

New York Times Examines India’s Growing Influence On Global Drug Industry

“India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West,” the New York Times writes in a piece that examines what the role could mean for the country as well as for the global drug industry.

UNITAID Concerned About Infant HIV Medication Shortage, Drug Company Says Supply Is Sufficient

Bristol-Myers Squibb’s plans this month to close its plant in Meymac, France, that manufactures “the last therapeutic option” for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet (.pdf), UNITAID writes that “[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need.”

BMJ Report Questions WHO Advisors’ Ties To Pharmaceutical Industry

“Key scientists behind World Health Organization advice on stockpiling of pandemic flu drugs had financial ties with companies which stood to profit,” according to a joint investigation by BMJ in collaboration with the Bureau of Investigative Journalism, BBC News reports (6/4).

World Health Assembly News

Media outlets continue to track news emerging from the 63rd annual World Health Assembly (WHA) in Geneva.